Skip to main content
. 2023 Mar 11;47(1):34. doi: 10.1007/s10916-023-01933-4

Table 3.

Outcomes from validated scales, health utilization and drug utilization in intervention and usual care groups at Follow-Up

Outcomes Intervention (N = 24) Usual care (N = 25) p-value
Validated scale
e-health 20.0 (6.1) 18.4 (6.7) 0.41
Medication adherence 35.0 (1.3) 34.5 (3.3) 0.48
Diet adherence 27.6 (4.7) 26.2 (5.4) 0.33
Self-efficacy
  Bad 21 (88%) 23 (92%) 0.67
  Good 3 (12%) 2 (8%)
Literacy
  2 1 (4%) 0 (0%) 0.42
  3 2 (8%) 5 (20%)
  4 21 (88%) 20 (80%)
Exercise
  Insufficient 14 (58%) 9 (36%) 0.29
  Moderately active 6 (25%) 11 (44%)
  Active 4 (17%) 5 (20%)
Health Utilization
No. of attendance in AED
  0 21 (88%) 23 (92%) 0.67
  1 3 (12%) 2 (8%)
No. of attendance in SOPC
  0 18 (75%) 16 (64%) 0.31
  1 3 (12%) 6 (24%)
  2 1 (4%) 3 (12%)
  3 2 (8%) 0 (0%)
No. of hospital admission
  0 24 (100%) 23 (92%) 0.49
  1 0 (0%) 2 (8%)
No. of Visit to private physician
  No visit 20 (83%) 19 (76%) 0.57
  1–2 Visits 3 (12%) 4 (16%)
  3–4 visits 0 (0%) 2 (8%)
  >=7 visits 1 (4%) 0 (0%)
Drug Utilization
Use of diuretics
  No 23 (96%) 25 (100%) 0.49
  Yes 1 (4%) 0 (0%)
Use of betablockers
  No 22 (92%) 23 (92%) 1.00
  Yes 2 (8%) 2 (8%)
Use of CCB
  No 2 (8%) 8 (32%) 0.074
  Yes 22 (92%) 17 (68%)
Use of ARB/ACEI
  No 19 (79%) 11 (44%) 0.012*
  Yes 5 (21%) 14 (56%)

P-value < 0.05 (marked by *) was considered statistically significant